Temsirolimus
Tocris Bioscience | Catalog # 5264
Key Product Details
Description
Alternative Names
Product Description
Temsirolimus is a mTOR inhibitor; inhibits tumor growth in breast cancer cell lines (IC50 values are 1.6 and 4.3 nM for SKBr3 and BT474, respectively). Inhibits HIF-1α-mediated VEGF production in breast cancer cell lines (BT474 and MDA-MB-231). Directly inhibits serum and VEGF mediated endothelial cell proliferation and morphogenesis in vitro and vessel formation in vivo. Causes G1/S cell cycle arrest in multiple cancer cell lines. Antiangiogenic. Activates autophagy.Licensing Information
Sold for research purposes under agreement from Pfizer Inc.
Product Specifications for Temsirolimus
Molecular Weight
Formula
Storage
Purity
Chemical Name
CAS Number
PubChem ID
InChI Key
SMILES
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 103.03 | 100 | |
| Ethanol | 103.03 | 100 |
Preparing Stock Solutions for Temsirolimus
The following data is based on the product molecular weight 1030.29.
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 0.97 mL | 4.85 mL | 9.71 mL |
| 5 mM | 0.19 mL | 0.97 mL | 1.94 mL |
| 10 mM | 0.10 mL | 0.49 mL | 0.97 mL |
| 50 mM | 0.02 mL | 0.10 mL | 0.19 mL |
Calculators
Background References
References are publications that support the biological activity of the product. See our Citations tab to view 9 publications citing the usage of this product.
- Galluzzi Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles. Nat.Rev.Drug.Discov. 2017 PMID: 28529316
- Li The novel mTOR inhibitor CCI-779 (temsirolimus) induces antiproliferative effects through inhibition of mTOR in Bel-7402 liver cancer cells. Cancer Cell Int. 2013 PMID: 23537100
- Del Bufalo Antiangiogenic potential of the Mammalian target of rapamycin inhibitor temsiro. Cancer Res. 2006 PMID: 16740688
- Wu L Effects of the mammalian target of rapamycin inhibitor CCI-779 used alone or with chemotherapy on human prostate cancer cells and xenografts. Cancer Res. 2005 PMID: 15805283
- Wang Inhibition of mammalian target of rapamycin signaling by CCI-779 (temsirolimus) induces growth inhibition and cell cycle arrest in Cashmere goat fetal fibroblasts (Capra hircus). DNA Cell Biol. 2012 PMID: 22320865
Product Documents for Temsirolimus
Certificate of Analysis
To download a Certificate of Analysis, please enter a lot or batch number in the search box below.
Product Specific Notices for Temsirolimus
For research use only
Related Research Areas
Citations for Temsirolimus
Customer Reviews for Temsirolimus (1)
Have you used Temsirolimus?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review
-
Species: MouseAssay Type: In VivoVerified Customer | Posted 08/13/2021Conditioned place aversion. Systemic administration
There are no reviews that match your criteria.